The EU's medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people.

The cocktail of two antiretroviral (ARV) drugs, rilpivirine and cabotegravir, can be given every few months instead of a daily pill to keep HIV infection under control.

"The two medicines are the first ARVs that come in a long-acting injectable formulation," the European Medicines Agency said in a statement.

"This means that instead of daily pills, patients receive intramuscular injections monthly or every two months," the Amsterdam-based agency said.

The EMA's recommendation for marketing authorisation must now be approved by the European Commission before it can be prescribed across the 27-nation bloc.

The injectable version of the drugs could be transformative for people with HIV.

People who forget to take their daily, lifelong doses of HIV medication run the risk of the virus rebounding to make them ill.

They can also develop resistance to the drugs they are using -- which would require a more expensive replacement.

The new cocktail of rilpivirine and cabotegravir -- branded as Rekambys and Vocabria -- work together "to block the ability of the virus to replicate," the EMA said.

The agency said the injectable treatment is a "significant improvement... by reducing the burden associated with daily pill taking."

Around 38 million people around the world were living with HIV in 2019, according to World Health Organization figures, with some 2.3 million people in Europe.

There is no cure for the HIV infection but ARV therapies can control the virus, help prevent transmission and allow patients to live longer.

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Covid-19 claims over 10,000 lives in Iraq
Baghdad (AFP) Oct 14, 2020
Iraq's health ministry said Wednesday that more than 10,000 people have died from Covid-19 in the country whose threadbare health sector has been battered by the virus. Iraq has registered more than 413,000 cases, and the total death toll now stands at 10,021, the ministry said. Neighbouring Iran has recorded around three times as many fatalities, the highest toll in the region. Baghdad recently lifted restrictions and reopened mosques, shops and cafes but has kept its borders closed to non- ... read more